University Health Network, Toronto: Bipolar Disorder trials
The registry lists 12 Bipolar Disorder studies with University Health Network, Toronto as lead sponsor. 1 are open to participants now and 1 have results posted.
Early Phase 1 1Phase 1 2Phase 2 2Phase 3 3Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Brain Insulin Resistance in Mood DisordersRecruitingNCT03915613Phase 1/2
- 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II DepressionCompletedNCT02363738Phase 2Results posted
- Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar DepressionActive, not recruitingNCT06506019Phase 1
- Treatment of Bipolar Depression With PentoxifyllineCompletedNCT04417049Early Phase 1
- Comparing Different Patterns of rTMS in Major DepressionStatus unknownNCT02778035Not applicable
- Cognitive Dysfunction and Glucagon-like Peptide-1 AgonistsCompletedNCT02423824Phase 3
- Deep Brain Stimulation for the Treatment of Refractory Bipolar DisorderCompletedNCT01476527Not applicable
- Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar DepressionCompletedNCT01403662Phase 3
- To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II DisorderCompletedNCT01263548
- The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar DisorderCompletedNCT00314314Phase 3
- Psychoeducation Versus Cognitive-Behavioral Therapy in Bipolar DisorderStatus unknownNCT00188838Not applicable
- Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II DepressionCompletedNCT00188643Phase 4